A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

Completed · Phase 3 · Has a placebo group

Conditions studied: Breast Cancer

In brief

This study is looking at whether Metformin, an agent that is commonly used to treat diabetes, can decrease or affect the ability of breast cancer cells to grow and whether Metformin will work with other therapies to keep cancer from recurring. Health Canada has not approved the sale or use of Metformin to treat breast cancer, although they have approved its use in this clinical trial. Although Metformin is approved by the FDA for the treatment of diabetes, its use in breast cancer is considered investigational.

Key facts

Study ID
NCT01101438
Run by
Canadian Cancer Trials Group
People needed
3649
Starts
2010-08-13
Expected to finish
2023-08-18
Last updated by the study team
2023-09-13

Who can join

Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.